Rottapharm SpA
26Patents
20Active
26Granted
41Portfolio score
Filing activity: Mar 17, 1986 → Jan 4, 2021 · 14 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7674809B2 | Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production | Chemistry; Metallurgy | 13 | Active |
| US4705855A | 1-[2-(2,4-dichlorophenyl)-2-(4-substituted piperazine)ethyl]-1H-imidazoles having antimycotic and antibacterial activities, pharmaceutical compositions containing them | Chemistry; Metallurgy | 10 | Expired |
| US4758567A | 7-(4-amino-piperazinyl)- or 7-(4-chloro-piperazinyl)quinolinone and azaquinolinone derivatives and pharmaceutical compositions containing them | Chemistry; Metallurgy | 5 | Expired |
| US7994181B2 | 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents | Chemistry; Metallurgy | 3 | Active |
| US7482371B2 | N-phenylbenzamide derivatives as drugs for the treatment of COPD | Human Necessities | 1 | Expired |
| US8420634B2 | Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologies | Chemistry; Metallurgy | 1 | Active |
| US7294648B2 | Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof | Chemistry; Metallurgy | 0 | Expired |
| US8258185B2 | Use of neboglamine in the treatment of toxicodependency | Human Necessities | 0 | Active |
| US7824710B2 | Crystalline and stable form of andolast | Human Necessities | 0 | Active |
| US8193353B2 | 6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents | Chemistry; Metallurgy | 0 | Active |
| US7846921B2 | Method of relieving symptoms of gastroesophageal reflux disease | Human Necessities | 0 | Active |
| US9623108B2 | Formulation for oral administration with beneficial effects on the cardiovascular system | Human Necessities | 0 | Active |
| US7863330B2 | Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders | Human Necessities | 0 | Active |
| US11234997B2 | Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments | Human Necessities | 0 | Active |
| US7906501B2 | Pyrrole derivatives with angiotensin II antagonist activity | Human Necessities | 0 | Expired |
| US7662994B2 | Method for the preparation of crystalline dexloxiglumide and products obtained | Human Necessities | 0 | Expired |
| US8809306B2 | Combination andolast/glucocorticoids | Human Necessities | 0 | Active |
| US9062129B2 | Hyaluronic acid esters, their preparation and use in dermatology | Human Necessities | 0 | Active |
| US7737180B2 | Use of neboglamine (CR 2249) as an antipsychotic and neuroprotective | Human Necessities | 0 | Active |
| US8372866B2 | 2-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain | Chemistry; Metallurgy | 0 | Active |
| US10912747B2 | Antimicrobial composition | Human Necessities | 0 | Active |
| US11998517B2 | Antimicrobial composition | Human Necessities | 0 | Active |
| US8633208B2 | 6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands | Chemistry; Metallurgy | 0 | Active |
| US9174966B2 | Crystalline forms of 6-(1H-imidazol-1-yl)-2-phenylquinazoline | Human Necessities | 0 | Active |
| US7906551B2 | 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective COX-2 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.